Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

Industry at a 'turning point' with growth dominated by commercial leaders: EY report

21 October 2026 · By · Wire by Fusion42

Published

21 October 2026

Topic

opportunities

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at fiercebiotech.com →

◆ Verified

Fusion42 · 21 October 2026 · Fusion42 review

The medtech industry achieved record revenue growth and M&A activity through 2025 and early 2026, driven by commercial leaders and accelerated AI integration in medical devices. Despite global challenges, AI-enabled devices are rapidly increasing, signalling a shift towards digital and data-driven product offerings.

This Wire brief sits within Fusion42's coverage of Medtech.

◆ ◆ The Wire takeaway

You must embed AI deeply into your medtech products and bundles now to compete with commercial leaders. The rapid rise in AI authorizations means legacy device makers will lose ground unless they digitise fast.

◆ Coverage

1 source · 21 Oct 2026

◆ Related on Wire

◆ Topics

Medtechmedtech-growthai-in-medical-devicesm&a-activityindustry-report